Interesting facts
              Interesting Facts about 3-(5,5-Dioxophenothiazin-10-yl)-N,N,2-trimethyl-propan-1-amine
This compound, known for its complex structure, is part of a class of chemicals that often have significant biological activity. Here are some intriguing insights about this compound:
- Pharmacological Significance: Many compounds related to phenothiazine derivatives exhibit neuroleptic properties, which are essential for the treatment of various psychiatric disorders.
 - Structural Characteristics: The presence of both a thiazine and a tertiary amine in its structure contributes to its unique chemical behavior, affecting how it interacts with biological systems.
 - Potential Uses: Research indicates that compounds similar to this can be explored for their potential in developing new therapeutic agents, particularly in the field of antipsychotic medications.
 - Research Focus: Ongoing studies are investigating how the modifications in the molecular structure influence pharmacodynamics and pharmacokinetics, which can lead to better-targeted therapies.
 
As noted by researchers, “Understanding the intricate balance between structure and function in these compounds opens up new avenues for drug development.”
In conclusion, 3-(5,5-dioxophenothiazin-10-yl)-N,N,2-trimethyl-propan-1-amine is a prime example of how structural variation can lead to diverse biological activities, thus paving the way for innovations in medicinal chemistry.
Synonyms
          Oxomemazine
          3689-50-7
          Dysedon
          Doxergan
          Imakol
          Oxymemazine
          Dosegran
          Oxomemazina
          Alimemazine S,S-dioxide
          Oxomemazinum
          Oplex
          Exe-top
          Oxomemazine [INN:DCF]
          Trimeprazine 5,5-dioxide
          Oxomemazinum [INN-Latin]
          RP 6847
          Oxomemazina [INN-Spanish]
          EINECS 222-996-8
          Doxergan (TN)
          Oxomemazine (INN)
          RP-6847
          BRN 0289178
          10-(3-(Dimethylamino)-2-methylpropyl)phenothiazine 5,5-dioxide
          10-(3-(Dimethylamino)-2-methylpropyl)phenothiazine-5,5-dioxide
          6847 R.P.
          305MB38V1C
          OXOMEMAZINE [MI]
          OXOMEMAZINE [INN]
          6487-RP
          6847-RP
          10H-Phenothiazine-10-propanamine, N,N,.beta.-trimethyl-, 5,5-dioxide
          OXOMEMAZINE [MART.]
          OXOMEMAZINE [WHO-DD]
          DTXSID5023405
          4-27-00-01270 (Beilstein Handbook Reference)
          Dioxo-9,9-(dimethylamino-3-methyl-2-propyl)-10-phenothiazine [French]
          PHENOTHIAZINE, 10-(3-(DIMETHYLAMINO)-2-METHYLPROPYL)-, 5,5-DIOXIDE
          (+-)-Oxomemazine
          Dioxo-9,9-(dimethylamino-3-methyl-2-propyl)-10-phenothiazine
          Oxomemazinum (INN-Latin)
          Oxomemazina (INN-Spanish)
          OXOMEMAZINE (MART.)
          Phenothiazine, 10-[3-(dimethylamino)-2-methylpropyl]-, 5,5-dioxide
          10-(3-(dimethylamino)-2-methylpropyl)-10H-5lambda6-phenothiazine-5,5-dione
          10-[3-(dimethylamino)-2-methylpropyl]-10H-5lambda6-phenothiazine-5,5-dione
          DTXCID103405
          R06AD08
          10H-Phenothiazine-10-propanamine, N,N,beta-trimethyl-, 5,5-dioxide
          222-996-8
          10-(3-(diMethylaMino)-2-Methylpropyl)-10H-phenothiazine 5,5-dioxide
          (+)-Oxomemazine
          (-)-Oxomemazine
          3-(5,5-dioxophenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine
          Oxomemazine, (+)-
          Oxomemazine, (-)-
          Q824SGH3RN
          (+/-)-OXOMEMAZINE
          5GP9538P4S
          174508-14-6
          Oxomemazin
          Trimeprazine Sulphone; Oxomemazine
          174508-13-5
          NCGC00182075-03
          UNII-305MB38V1C
          MFCD00868197
          UNII-Q824SGH3RN
          MLS006009989
          SCHEMBL423634
          UNII-5GP9538P4S
          CHEMBL2104734
          CHEBI:135408
          ARD14338
          Oxomemazine 1.0 mg/ml in Methanol
          AKOS015962134
          6487 RP
          6847 RP
          DB13820
          NCGC00182075-02
          1ST14338
          AC-15943
          DA-76517
          MS-24971
          SMR004701064
          HY-136587
          CS-0131898
          NS00002586
          D07401
          F20164
          SR-01000883964
          Q3359071
          SR-01000883964-1
          10H-Phenothiazine-10-propanamine, N,N,beta-trimethyl-, 5,5-dioxide, (+)-
          10H-Phenothiazine-10-propanamine, N,N,beta-trimethyl-, 5,5-dioxide, (-)-
          3-(5,5-Dioxido-10H-phenothiazin-10-yl)-N,N,2-trimethyl-1-propanamine #
          3-(5,5-dioxido-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine
          10H-PHENOTHIAZINE-10-PROPANAMINE, N,N,.BETA.-TRIMETHYL-, 5,5-DIOXIDE, (+)-
          10H-PHENOTHIAZINE-10-PROPANAMINE, N,N,.BETA.-TRIMETHYL-, 5,5-DIOXIDE, (-)-
              
Solubility of 3-(5,5-dioxophenothiazin-10-yl)-N,N,2-trimethyl-propan-1-amine
The compound 3-(5,5-dioxophenothiazin-10-yl)-N,N,2-trimethyl-propan-1-amine exhibits interesting solubility characteristics, which can be influenced by various factors. Understanding its solubility is essential in applications such as pharmaceuticals and environmental chemistry.
Here are some crucial points to note regarding its solubility:
In summary, while the specific solubility data for 3-(5,5-dioxophenothiazin-10-yl)-N,N,2-trimethyl-propan-1-amine requires further empirical investigation, factors like solvent polarity, temperature, pH, and potential complexation role play vital roles in determining its overall solubility. Understanding these aspects is key in optimizing its usage in various applications.